Merge Healthcare Inc.  

(Public, NASDAQ:MRGE)   Watch this stock  
Find more results for Matthew Hammonds
7.09
0.00 (0.00%)
Aug 28 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 7.09 - 7.11
52 week 2.04 - 7.13
Open 7.09
Vol / Avg. 800,394.00/2.34M
Mkt cap 701.18M
P/E 41.47
Div/yield     -
EPS 0.17
Shares 98.90M
Beta 1.94
Inst. own 40%
Oct 27, 2015
Q3 2015 Merge Healthcare Inc Earnings Release (Estimated) - 9:30AM EDT - Add to calendar
Jul 23, 2015
Q2 2015 Merge Healthcare Inc Earnings Release
Jul 23, 2015
Q2 2015 Merge Healthcare Inc Earnings Call
Jun 17, 2015
Merge Healthcare Inc Annual Shareholders Meeting
More events from DailyFinance »    

Key stats and ratios

Q2 (Jun '15) 2014
Net profit margin 3.02% -0.19%
Operating margin 13.82% 8.86%
EBITD margin - 19.53%
Return on average assets 1.77% -0.11%
Return on average equity 5.19% -0.94%
Employees 800 -
CDP Score - -

Address

350 N Orleans St
CHICAGO, IL 60654-1975
United States - Map
+1-312-5656868 (Phone)
+1-312-5656870 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Merge Healthcare Incorporated develops software solutions that facilitate the sharing of images. The Company operates through two segments: Merge Healthcare and Merge DNA. The Company's Merge Healthcare segment markets, sells and implements interoperability, imaging and clinical solutions to healthcare providers. The Company's Merge DNA (Data and Analytics) segment focuses on the marketing and sale of data capture software for clinical trials and related solutions. The Merge Healthcare segment offers licensing of software (including upgrades), the sale of hardware, professional services, maintenance and electronic data interchange (EDI) services. The Merge DNA segment offers on-premise licensing and hosting arrangements, and professional services.

Officers and directors

Michael W. Ferro Jr. Chairman of the Board
Age: 48
Bio & Compensation  - Reuters
Justin C. Dearborn CPA Chief Executive Officer, President and Corporate Secretary, Director
Age: 45
Bio & Compensation  - Reuters
Steven M. Oreskovich CPA Chief Financial Officer, Treasurer
Age: 43
Bio & Compensation  - Reuters
Nancy J. Koenig Chief Operating Officer
Age: 50
Bio & Compensation  - Reuters
Antonia A. Wells Executive Vice President - Research and Development
Age: 56
Bio & Compensation  - Reuters
Kurt R. Hammond Chief Marketing and sales Officer
Age: 48
Bio & Compensation  - Reuters
Michael P. Cole Director
Age: 43
Bio & Compensation  - Reuters
William J. Devers Jr. Director
Age: 81
Bio & Compensation  - Reuters
Matthew M. Maloney Director
Age: 39
Bio & Compensation  - Reuters
Richard A. Reck Independent Director
Age: 65
Bio & Compensation  - Reuters